Quantum BioPharma Announces Corporate Updates
Toronto, Ontario--(Newsfile Corp. - September 26, 2025) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) (Upstream: QNTM) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development, today announces the following corporate
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-09-26 8:00 PM EDT | Quantum BioPharma Ltd.
Neural's Partner Hanf.com Expands Retail Footprint with 17th Store Opening Near Munich
Toronto, Ontario--(Newsfile Corp. - September 23, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic solutions for substance use disorders, together with CWE European Holdings Inc. ("CWE"), operating as Hanf.com, one of Germany's leading CBD retailers, is pleased to announce the opening of its 17t
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-09-23 12:16 PM EDT | Neural Therapeutics Inc.
Optimind Pharma Announces Definitive Agreement for Proposed Change of Business with InterviewDesk
Toronto, Ontario--(Newsfile Corp. - September 8, 2025) - Optimind Pharma Corp. (CSE: OMND) (the "Optimind" or the "Company") is pleased to announce that it has entered into a binding definitive share exchange agreement dated September 5, 2025 (the "SEA") with IDesk Technologies Private Limited ("InterviewDesk"), a private company incorporated under laws of India, and its principal shareholders in respect of an arm's length transaction (the "Transaction") whi
Biotechnology, Cannabis, Health, Psychedelics
2025-09-08 3:18 PM EDT | Optimind Pharma Corp.
Optimi Announces Public Filing of Registration Statement for Proposed U.S. Initial Public Offering
Vancouver, British Columbia--(Newsfile Corp. - September 8, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company") a Canadian drug manufacturer of MDMA and naturally-derived psilocybin announces that it has publicly filed a registration statement with the U.S. Securities and Exchange Commission (the "SEC") relating to a proposed initial public offering of its common shares in the United States. The number of common share
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-09-08 7:00 AM EDT | Optimi Health Corp.
Optimind Pharma Announces Termination of Letter of Intent
Toronto, Ontario--(Newsfile Corp. - September 4, 2025) - Optimind Pharma Corp. (CSE: OMND) (the "Optimind" or the "Company") announces that its previously announced non-binding letter of intent dated March 18, 2025 with Monjin Interviews Private Limited ("Monjin"), with respect to the Company's acquisition of Monjin, has been mutually terminated by the parties. The Company is continuing to evaluate and review alternative acquisition opportunities. About the
Biotechnology, Cannabis, Health, Psychedelics
2025-09-04 4:00 PM EDT | Optimind Pharma Corp.
Red Light Holland's Wholly Owned Subsidiary Happy Caps Mushroom Farm Secures Continued Safeway Partnership to 123 Stores Across Two Seasonal Programs in the U.S.
Toronto, Ontario--(Newsfile Corp. - September 4, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), a company engaged in the production, growth and sale of functional mushrooms and mushroom home grow kits in North America and Europe, is pleased to announce its secured an expansion milestone for its wholly owned subsidiary, 4316747 Nova Scotia Limited o/a Happy Caps Mushroom Farms ("Happy Caps") with Albertsons Companies and it's Safew
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-09-04 8:01 AM EDT | Red Light Holland Corp.
Optimi Health Announces Launch of Psilocybin Capsules in Australia for Treatment-Resistant Depression
Vancouver, British Columbia--(Newsfile Corp. - September 3, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Canadian manufacturer of GMP psychedelic medicines, is pleased to announce the commercial launch of its natural psilocybin capsules in Australia, which are now being prescribed to patients with Treatment-Resistant Depression ("TRD") under the Authorised Prescriber Scheme. The initial shipment of 1,000 psilocybin capsules, each conta
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-09-03 7:30 AM EDT | Optimi Health Corp.
Numinus Wellness Inc. Announces Third Quarter Fiscal 2025 Results
Vancouver, British Columbia--(Newsfile Corp. - September 3, 2025) - Numinus Wellness Inc. (TSX: NUMI) (OTCQB: NUMIF) (FSE: LR23) ("Numinus" or the "Company") a mental health care company focused on innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, today announced its financial results for the three months ended May 31, 2025 ("Q3 2025 "). "Th
2025-09-03 7:00 AM EDT | Numinus Wellness Inc.
Telescope Innovations Appoints Vaso Vlachos as Chief Operating Officer
Vancouver, British Columbia--(Newsfile Corp. - September 2, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope Innovations", "Telescope", or the "Company"), a leader in intelligent automation platforms for accelerating chemical process development, is pleased to announce the appointment of Vaso Vlachos as Chief Operating Officer (COO), effective immediately. Ms. Vlachos is a proven leader with over 20 years of experience managing automation and an
Technology, Chemical, Pharmaceuticals, Psychedelics
2025-09-02 8:00 AM EDT | Telescope Innovations Corp.
Red Light Holland Reports First Quarter 2026 Results
Toronto, Ontario--(Newsfile Corp. - August 28, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms, mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truffles to the legal recreational market within the Netherlands, in compliance with all applicable laws, announces its financial and operational results f
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-08-28 7:40 AM EDT | Red Light Holland Corp.
Red Light Holland Updates Bitcoin Balance Sheet Strategy
Toronto, Ontario--(Newsfile Corp. - August 26, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, as well as a premium brand of psilocybin truffles in the legal, recreational market within the Netherlands, today announced an update on its Bitcoin balance sheet strategy.
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-08-26 8:23 AM EDT | Red Light Holland Corp.
Numinus Wellness Inc. Announces Second Quarter Fiscal 2025 Results
Vancouver, British Columbia--(Newsfile Corp. - August 20, 2025) - Numinus Wellness Inc. (TSX: NUMI) (OTCQB: NUMIF) (FSE: LR23) ("Numinus" or the "Company"), a mental health care company focused on innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, today announced its financial results for the three months ended February 28, 2025 ("Q2 2025").
2025-08-20 5:24 PM EDT | Numinus Wellness Inc.
Steep Hill Announces Appointment of Director
Toronto, Ontario--(Newsfile Corp. - August 20, 2025) - Steep Hill Inc. (CSE: STPH) ("Steep Hill" or the "Company") is pleased to announce that Ms. Sonia Agustina has been appointed as a Director of the Company, effective August 13, 2025. Ms. Agustina is a Chartered Professional Accountant with over 20 years of financial leadership experience in both public practice and industry, specializing in regulated, high-growth, and publicly listed companies. She currently serves
Retail, Cannabis, Psychedelics, Cannabis Manufacturer
2025-08-20 5:00 PM EDT | Steep Hill Inc.
Red Light Holland Applauds HHS Review of Psilocybin Rescheduling Petition, Expresses Optimism for Reversal of Schedule I Classification
Toronto, Ontario--(Newsfile Corp. - August 20, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, and a premium brand of magic truffles to the legal, recreational market within the Netherlands, today welcomes the U.S. Drug Enforcement Administration's (DEA) decision to forward a psil
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-08-20 8:43 AM EDT | Red Light Holland Corp.
Optimi Health Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - August 20, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a manufacturer of GMP-certified MDMA and psilocybin, is pleased to announce it has entered into an agreement with MZ Investor Relations ("MZ"), an investor relations firm. MZ will provide Optimi with strategic support in capital markets advisory, corporate communications, and investor engagement. Under the te
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-08-20 7:30 AM EDT | Optimi Health Corp.
Red Light Holland Receives Initial Third-Party Psilocybin Testing Results via FDA-Compliant, DEA-Registered Partner, Irvine Labs
Toronto, Ontario--(Newsfile Corp. - August 18, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporatio
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-08-18 8:16 AM EDT | Red Light Holland Corp.
Neural Announces Completion of the Acquisition of a 30.75% Interest in Hanf.com, a Profitable German CBD Retail Store Chain
Toronto, Ontario--(Newsfile Corp. - August 13, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-08-13 7:30 AM EDT | Neural Therapeutics Inc.
Quantum BioPharma Announces Update to Previously Announced Private Placement
Toronto, Ontario--(Newsfile Corp. - August 11, 2025) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, announces that further to its press release dated June 27, 2025, the Company will be seeking shareholder approval of its non-brokered private placement of class A multiple voting shares ("MVS") for aggregate gross
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-08-11 6:32 PM EDT | Quantum BioPharma Ltd.
Numinus Wellness Inc. Announces First Quarter Fiscal 2025 Results
Vancouver, British Columbia--(Newsfile Corp. - August 8, 2025) - Numinus Wellness Inc. (TSX: NUMI) (OTCQB: NUMIF) (FSE: LR23) ("Numinus" or the "Company"), a mental health care company focused on innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, today announced its financial results for the three months ended November 30, 2024 ("Q1 2025").
2025-08-08 5:00 PM EDT | Numinus Wellness Inc.